Abbott Laboratories (ABT)

NYSE: ABT · IEX Real-Time Price · USD

110.07

-0.33 (-0.30%)

At close: Dec 29, 2023, 4:00 PM

110.00

-0.07 (-0.06%)

After-hours: Dec 29, 2023, 7:40 PM EST

Abbott Laboratories Stock Forecast

Stock Price Forecast

According to 14 stock analysts, the average 12-month stock price forecast for ABT stock stock is $124.5, which predicts an increase of 13.11%. The lowest target is $107 and the highest is $136. On average, analysts rate ABT stock stock as a strong buy.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$107	$124.5	$130	$136
Change	-2.79%	+13.11%	+18.11%	+23.56%

Analyst Ratings

The average analyst rating for ABT stock from 15 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jul '23	Aug '23	Sep '23	Oct '23	Nov '23	Dec '23
Strong Buy	9	9	9	7	7	6
Buy	10	10	10	10	10	6
Hold	4	4	4	3	3	3
Sell	0	0	0	0	0	0
Strong Sell	1	1	1	0	0	0
Total	24	24	24	20	20	15

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Lawrence Biegelsen Wells Fargo	Wells Fargo	Buy Maintains $116 → $121	Buy	Maintains	$116 → $121	+9.93%	Dec 13, 2023
David Lewis Morgan Stanley	Morgan Stanley	Hold Maintains $112 → $107	Hold	Maintains	$112 → $107	-2.79%	Oct 19, 2023
Lawrence Biegelsen Wells Fargo	Wells Fargo	Buy Maintains $136 → $116	Buy	Maintains	$136 → $116	+5.39%	Oct 19, 2023
Jayson Bedford Raymond James	Raymond James	Buy Maintains $123 → $110	Buy	Maintains	$123 → $110	-0.06%	Oct 19, 2023
Matt Miksic Barclays	Barclays	Buy Maintains $127 → $132	Buy	Maintains	$127 → $132	+19.92%	Jul 24, 2023

Full Analyst Rating History

Financial Forecast

Revenue This Year

40.47B

from 43.65B

-7.30%

from 43.65B

Revenue Next Year

42.09B

from 40.47B

4.02%

from 40.47B

EPS This Year

4.48

from 3.91

14.66%

from 3.91

EPS Next Year

4.67

from 4.48

4.15%

from 4.48

Year	2018	2019	2020	2021	2022	2023	2024	2025	2026	2027	2028
Revenue	30.58B	31.90B	34.61B	43.08B	43.65B	40.47B	42.09B	45.09B	47.72B	50.64B	55.99B
Revenue Growth	11.64%	4.34%	8.48%	24.47%	1.34%	-7.30%	4.02%	7.13%	5.83%	6.10%	10.58%
EPS	1.33	2.06	2.50	3.94	3.91	4.48	4.67	5.18	5.62	6.10	7.38
EPS Growth	392.59%	54.89%	21.36%	57.60%	-0.76%	14.66%	4.15%	11.02%	8.34%	8.69%	20.96%
No. Analysts	-	-	-	-	-	25	25	19	5	4	2

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2023	2024	2025	2026	2027	2028
High	42.6B	45.3B	48.5B	50.3B	54.2B	58.2B
Avg	40.5B	42.1B	45.1B	47.7B	50.6B	56.0B
Low	39.1B	40.2B	42.7B	45.0B	47.4B	54.3B

Revenue Growth

Revenue Growth	2023	2024	2025	2026	2027	2028
High	-2.4%	12.0%	15.2%	11.6%	13.6%	15.0%
Avg	-7.3%	4.0%	7.1%	5.8%	6.1%	10.6%
Low	-10.4%	-0.5%	1.4%	-0.3%	-0.6%	7.3%

EPS Forecast

EPS	2023	2024	2025	2026	2027	2028
High	4.69	4.99	5.63	6.13	6.87	7.68
Avg	4.48	4.67	5.18	5.62	6.10	7.38
Low	4.31	4.39	4.73	5.17	5.42	7.16

EPS Growth

EPS Growth	2023	2024	2025	2026	2027	2028
High	20.0%	11.3%	20.5%	18.3%	22.3%	25.8%
Avg	14.7%	4.1%	11.0%	8.3%	8.7%	21.0%
Low	10.3%	-2.1%	1.4%	-0.2%	-3.5%	17.4%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.